Internal Medicine, Clinical Cardiatric Electrophysiology · Wichita, KS
NPI
1619921855
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3311 E Murdock
Wichita, KS, 67208
Phone (316) 689-9370
Groups this clinician bills Medicare through
Medicare paid, 2024
$310K
6,962 services
Medicare patients, 2024
1,118
Average age 76
Drug cost, 2024
$1.6M
6,263 prescriptions
Company payments, 2025
$976
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by P D Margolis was code 93298 (external electrocardiographic monitoring), 992 times for 150 patients. In total P D Margolis billed 6,962 services in 100 codes, and Medicare paid $310K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93298 External Electrocardiographic Monitoring | Facility | 992 | 150 | $18.14 | $18K |
| 93294 External Electrocardiographic Monitoring | Facility | 813 | 303 | $21.29 | $17K |
| 93297 External Electrocardiographic Monitoring | Facility | 606 | 98 | $18.13 | $11K |
| 93280 External Electrocardiographic Monitoring | Facility | 405 | 249 | $26.89 | $11K |
| 93295 External Electrocardiographic Monitoring | Facility | 360 | 143 | $26.20 | $9,433 |
| 93296 External Electrocardiographic Monitoring | Office | 287 | 280 | $10.75 | $3,084 |
| 99214 Office E&M - Established | Facility | 286 | 273 | $68.71 | $20K |
| 93294 External Electrocardiographic Monitoring | Office | 204 | 198 | $15.06 | $3,072 |
| 93298 External Electrocardiographic Monitoring | Office | 197 | 101 | $42.50 | $8,373 |
| 93306 Echocardiography (TTE/TEE) | Office | 173 | 172 | $131.36 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 170 | 64 | $58.13 | $9,882 |
| 99223 Hospital E&M - Initial | Facility | 149 | 137 | $127.80 | $19K |
| 93000 Electrocardiogram | Office | 145 | 127 | $6.89 | $998 |
| 93297 External Electrocardiographic Monitoring | Office | 130 | 78 | $23.43 | $3,046 |
| 93284 External Electrocardiographic Monitoring | Facility | 124 | 87 | $44.33 | $5,496 |
By year: 2022 $430K for 9,895 services; 2023 $448K for 10,913 services; 2024 $310K for 6,962 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 74 | 14 | $4.23 | $313 |
Medicare prescription drug claims, 2024
In 2024, the drug P D Margolis prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,081 prescriptions and refills. In total P D Margolis wrote 6,263 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,081 | 1,811 | 214 | $1.1M |
| Sotalol Sotalol Hcl | 712 | 1,728 | 175 | $16K |
| Metoprolol Succinate Generic | 560 | 1,359 | 168 | $6,377 |
| Amiodarone Hcl Generic | 508 | 1,079 | 139 | $7,640 |
| Flecainide Acetate Generic | 369 | 924 | 102 | $16K |
| Xarelto Rivaroxaban | 235 | 509 | 58 | $282K |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 224 | 533 | 70 | $4,336 |
| Warfarin Sodium Generic | 206 | 541 | 52 | $1,309 |
| Carvedilol Generic | 201 | 513 | 60 | $1,334 |
| Atorvastatin Calcium Generic | 193 | 538 | 56 | $1,248 |
| Furosemide Generic | 179 | 405 | 51 | $653 |
| Metoprolol Tartrate Generic | 174 | 444 | 49 | $618 |
| Amlodipine Besylate Generic | 166 | 430 | 57 | $508 |
| Entresto Sacubitril/Valsartan | 150 | 243 | 32 | $159K |
| Losartan Potassium Generic | 114 | 325 | 37 | $801 |
Brand drugs: 1,655 claims; generic drugs: 4,608 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid P D Margolis $976 ($976 in general payments such as food, travel and fees) from 5 companies. The largest payer was Medtronic, Inc. with $321.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.